Ghana News
Fuel Prices to Increase in Ghana from Next Week as NPA Sets New Price Floors Amid Middle East Conflict
ACCRA — The National Petroleum Authority (NPA) has announced sharp increases in minimum price floors for petroleum products effective March 16 to March 31, 2026, with diesel recording one of the steepest adjustments in recent years as global oil markets react to the ongoing conflict in the Middle East.
Under the new pricing guidelines, petrol will rise from GH¢10.46 to GH¢11.57 per litre, while diesel climbs from GH¢11.42 to GH¢14.35 per litre—a nearly 26 percent increase for diesel in a single pricing window. Liquefied Petroleum Gas (LPG) has also been adjusted upward to GH¢10.67 per kilogram, from GH¢9.38 previously.
The NPA directive, issued to Oil Marketing Companies (OMCs) and LPG Marketing Companies (LPGMCs), mandates compliance with the new price floors under the Petroleum Products Pricing Guidelines (PPPG). The quoted prices exclude premiums charged by International Oil Trading Companies, operating margins of Bulk Import, Distribution and Export Companies, and marketers’ and dealers’ margins—meaning consumers will pay significantly more once these additional costs are factored in.
Global Conflict, Local Impact
Industry analysts trace the sharp increases directly to escalating geopolitical tensions in the Middle East, where the joint US-Israeli conflict with Iran has disrupted global energy markets.
Dr Riverson Oppong, Chief Executive of the Chamber of Oil Marketing Companies (COMAC), warned earlier this month that fuel could reach GH¢17 per litre if the situation persists.
“If by Wednesday things have not come down, we are going to hit around $110 to $120 per barrel,” he said on March 9, noting that crude oil prices have already surged past $108 per barrel.
Duncan Amoah, Executive Secretary of the Chamber of Petroleum Consumers (COPEC), had projected prices between GH¢14 and GH¢16 per litre in a March 12 interview—projections that now appear conservative given the NPA’s new diesel floor of GH¢14.35 before additional levies.
The conflict has triggered multiple supply-side shocks. Brent crude surged more than 10 percent in early March trading, reaching $80.11 per barrel, with analysts projecting potential climbs to $90 or beyond. Missile strikes have hit OPEC members, including the UAE, Saudi Arabia and Kuwait, while attacks on oil tankers in the Gulf and Strait of Hormuz—through which 20 percent of global crude passes—have raised concerns about supply route security.
Qatar has reportedly halted natural gas production following bombings, and a major refinery with 550,000 barrels per day capacity has been shut down, further constraining global supply.
Discount Ban Compounds Price Pressure
The price floor increases coincide with the implementation of an NPA directive banning selective fuel discounts, which takes effect on the same date—March 16.
The directive closes a regulatory provision that allowed companies, including GOIL and Star Oil, to offer lower prices at designated stations. From March 16, all OMCs and LPGMCs must charge identical prices across their entire networks, ending the price competition that had moderated pump prices in many urban areas.
Dr Steve Manteaw, a natural resource governance expert, has urged the government to suspend the ban immediately, arguing the timing “is dangerously out of step with a global oil market already rattled by the ongoing conflict in the Middle East.”
“This directive ought to be reconsidered in the interest of containing the potential effects of the ongoing Middle East conflict on consumers,” Manteaw said. “In fact, the government should be considering the suspension of some taxes on petroleum products to stem potential price hikes”.
Dr Oppong of COMAC offered a different perspective, insisting the NPA had not scrapped discounting but corrected “a long-standing regulatory error”.
Vulnerability Exposed
The price shocks highlight Ghana’s structural exposure to global oil markets. Dr Oppong noted that Ghana remains a net importer of petroleum products, bringing in more than 60 percent of domestic requirements despite some local production.
“Availability and accessibility may not be a problem for us, but affordability is the big question,” he said.
Benjamin Nsiah, Executive Director of the Centre for Environmental Management and Sustainable Energy (CEMSE), had warned on March 2 that diesel could increase by at least 20 percent if global conditions persisted, noting that international diesel prices had surged from approximately $711–$775 per metric tonne to around $872 per metric tonne—a nearly 30 percent increase.
The cedi’s recent marginal appreciation against the dollar—from GH¢11.09 to GH¢11.04—provided limited cushioning but proved insufficient to offset the scale of global price movements.
Policy Options and Consumer Impact
Industry stakeholders are calling for government intervention to cushion consumers. Dr Oppong urged consideration of temporary tax relief measures, including suspension or reduction of the Price Stabilisation and Recovery Levy (PSRL).
“If prices increase, the government should consider removing certain levies or implementing measures to ease the burden on consumers,” he said.
Nsiah similarly suggested exploring alternative petroleum supply sources and policy tools including the possible removal of the GH¢1 levy on fuel and the use of auction policies to stabilize prices.
The new price floors mean no OMC or LPGMC may sell below approved levels during this window. Companies currently selling below these thresholds must adjust upward immediately to comply.
With additional levies, margins and operational charges yet to be factored in, consumers face substantially higher pump prices starting March 16. The ripple effects are expected to extend beyond motorists to transport fares, food costs and general inflation, given fuel’s central role in Ghana’s economy.
It remains unclear whether competition among OMCs will lead some to absorb portions of the cost increases, though the new discount restrictions may limit their flexibility.
The NPA has scheduled meetings with OMCs and LPGMCs to clarify the revised guidelines, but for Ghanaian consumers, the immediate reality is clear: fuel prices are rising sharply, and the end may not yet be in sight.
In a powerful demonstration of local ownership, Ghanaian research institutions and pharmaceutical manufacturers are contributing an additional €425,000 of their own money to implement innovative health projects, signaling a robust commitment to advancing homegrown medical solutions beyond relying on foreign aid alone.
The co-funding is part of a €2 million grant package awarded under the PharmaVax Ghana program, backed by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU).
The initiative is designed to bridge the critical gap between scientific discovery and industrial-scale manufacturing within Ghana.
While the grants provide vital financial fuel, the local co-investment—which ranges from €10,000 to €150,000 across the eight winning projects—represents a crucial “skin in the game” approach.
It shows that local institutions are not merely passive recipients of aid, but active stakeholders willing to risk their own capital to bring products to the market. This practical commitment underscores the sustainability of the projects, ensuring they are not abandoned once international funding cycles end.
The projects span a wide range of medical priorities, including fast-dissolving oral tablets for child-friendly malaria treatment, AI-powered diagnostic tools for Mpox and malaria, standardized herbal treatments for hypertension and liver disease, and stability data for locally produced tetanus-diphtheria vaccines.
Highlighting the importance of this local participation, Dr. Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute (NVI), emphasized that the funds are meant to catalyze local capabilities.
“Ghana has the scientific talent, the research institutions and an increasingly capable pharmaceutical industry to develop health solutions that respond to our own priorities,” he stated. “By bringing these strengths together, we are creating the foundation for medicines and vaccines that are developed in Ghana, manufactured in Ghana, and have the potential to benefit the wider region.”
Ghana’s Minister of Health, Hon. Kwabena Mintah Akandoh, echoed this sentiment, noting that the initiative marks a journey where researchers and manufacturers collaborate to transform scientific discoveries into life-saving products.
The €425,000 in local contributions—combined with the €2 million in grants and technical assistance from the EU and Germany—positions Ghana as a rising hub for pharmaceutical industrialization in West Africa, moving the nation closer to health security and economic self-reliance.
Ghana News
From Default to Discipline: How Ghana is Legally Binding Itself to Prevent the Next Debt Crisis
Fresh off a landmark agreement with Belgium that eases its debt burden, Ghana’s Finance Minister, Dr. Cassiel Ato Forson, has unveiled a sweeping package of legal and institutional reforms designed to permanently prevent the country from sliding back into the fiscal chaos that triggered its 2022 sovereign default.
The deal with Belgium to restructure €163 million in debt owed to the country’s Export Credit Agency marks a pivotal step towards completing Ghana’s broader debt restructuring program. Crucially, the agreement frees up much-needed “fiscal space” by slashing the amount of national revenue consumed by debt servicing. Minister Forson revealed that Ghana’s debt-service burden has fallen drastically from a crippling peak of roughly 50% to 55% of national revenue to less than 20% today—a shift that directly impacts the government’s ability to fund schools, hospitals, and roads.
However, the most significant aspect of Ghana’s strategy is its attempt to codify fiscal prudence into law, ensuring that the discipline learned from the crisis is not lost by future administrations.
A Three-Pronged Strategy for Fiscal Discipline
1. The Commitment Authorization Regime
At the core of the immediate controls is a strict mandate for all Ministries, Departments, and Agencies (MDAs). Under the amended Public Financial Management Act, no government institution can initiate a contract for goods, services, or works without first securing commitment authorization from the Finance Minister . This process, integrated with the Ghana Integrated Financial Management Information System (GIFMIS), acts as a “roadblock” to prevent overspending and the accumulation of hidden arrears—a practice that historically poisoned the country’s finances.
2. Binding Fiscal Rules in Law
Beyond day-to-day controls, the government has instituted statutory targets to ensure long-term solvency. The Public Financial Management Act has been amended to require a minimum annual primary surplus of 1.5% of GDP and to cap the national debt-to-GDP ratio at 45% by 2034 . These are not policy recommendations but binding legal requirements, with the Finance Minister potentially facing censure for breaching these targets.
3. Independent Oversight Institutions
To guarantee that fiscal responsibility is maintained even after Ghana concludes its International Monetary Fund (IMF) programme, the government has established two powerful oversight bodies:
- The Value for Money Office: Parliament passed the Value-for-Money Office Bill in March 2026, creating an independent body to scrutinize major public expenditure. This office will combat inflated contracts, cost overruns, and abandoned projects by issuing mandatory “Value for Money Certificates” before major contracts are awarded.
- The Independent Fiscal Council: The government is establishing a council composed of locally appointed experts to provide advisory support on financial controls and fiscal decision-making . This council, scheduled to take effect after the IMF programme ends, aims to strengthen domestic oversight and accountability, ensuring that Ghana owns its fiscal destiny.
From Recovery to Sustainability
Finance Minister Ato Forson is clear about the goal: “We want to ensure that the fiscal rules that we have instituted today are enshrined in law, so that even if this government is not there, the next government will have to make sure that these fiscal rules are respected” .
The Belgium agreement is the immediate piece of good news that provides tangible relief—allowing Ghana to redirect more resources towards essential public services. But the real measure of Ghana’s recovery will be its ability to enforce these new legal shackles.
By moving from crisis management to institutionalized discipline, Ghana is attempting to break the cycle of over-borrowing, arrears, and economic collapse that has plagued the nation for decades.
In a significant boost to Africa’s push for pharmaceutical self-reliance, the European Union (EU) and Germany have injected €2 million into Ghana to bridge the critical gap between laboratory research and industrial-scale manufacturing.
The funding, awarded under the PharmaVax Ghana programme, has been distributed to eight groundbreaking research partnerships aimed at developing and manufacturing medicines and vaccines locally, drastically reducing the continent’s historical reliance on imported drugs.
The announcement came during the “Research Meets Manufacturing” Award Ceremony in Accra on August 19, co-hosted by Ghana’s National Vaccine Institute (NVI) and the German development agency GIZ.
The grants are jointly funded by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU) as part of the broader Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+).
This strategic geopolitical and economic move underscores Western Europe’s commitment to backing local African manufacturing ecosystems, countering the long-standing structural imbalance where Africa imports over 90% of its pharmaceuticals.
“A ceremony marks the beginning of an important journey—a journey that brings researchers, manufacturers, government and international partners together to transform scientific discoveries into medicines and vaccines that save and improve lives,” said Hon. Kwabena Mintah Akandoh, Ghana’s Minister of Health, during the event.
Innovation Across the Health Spectrum
The eight winning projects, selected from 43 competitive proposals by an independent committee of nine Ghanaian experts, represent the breadth of the nation’s scientific talent. They include:
- AI-driven monoclonal antibodies and diagnostics for Mpox and malaria, using a Ghanaian artificial intelligence platform.
- Fast-dissolving oral tablets for the treatment of malaria in children, addressing critical issues of accurate dosing.
- Clinical trials for locally developed herbal treatments for prostate health, hypertension, and alcohol-related liver disease.
- Stability data generation to support regulatory approval of locally produced tetanus-diphtheria vaccines, snake venom antiserum, and pain management therapies.
A Foundation for Health Sovereignty
Dr. Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute, emphasized that the grants go far beyond financial aid.
“Ghana has the scientific talent, the research institutions and an increasingly capable pharmaceutical industry to develop health solutions that respond to our own priorities,” Dr. Sodzi-Tettey stated. “By bringing these strengths together, we are creating the foundation for medicines and vaccines that are developed in Ghana, manufactured in Ghana, and have the potential to benefit the wider region.”
Notably, Ghanaian partners are contributing an additional €425,000 towards implementing their projects, demonstrating a strong local commitment to advancing homegrown innovation. Alongside the direct funding, the projects will also receive technical assistance, networking opportunities, and knowledge exchange to ensure long-term commercial viability.
As the global health community increasingly looks to localized manufacturing to secure supply chains, this €2 million initiative serves as a pivotal case study.
It represents a concrete, actionable blueprint for how international development capital can ignite the “Made in Africa” pharmaceutical industrial wave, securing the continent’s health security and driving economic development from within.
Ghanaian Firms Inject €425,000 of Own Funds to Ignite ‘Made in Ghana’ Health Innovation
From Default to Discipline: How Ghana is Legally Binding Itself to Prevent the Next Debt Crisis
